1.13

35.06% -0.61

Inovio Pharmaceuticals Inc (INO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.74

Aprire:

$1.35

Volume 24 ore:

19.81M

Relative Volume:

13.51

Capitalizzazione di mercato:

$78.07M

Reddito:

$65,300

Utile/perdita netta:

$-84.95M

Rapporto P/E:

-0.5845

EPS:

-1.9332

Flusso di cassa netto:

$-88.92M

1 W Prestazione:

-27.10%

1M Prestazione:

-35.06%

6M Prestazione:

-54.07%

1 anno Prestazione:

-31.93%

Intervallo 1D:

$1.065

$1.36

Intervallo di 1 settimana:

$1.065

$1.785

Portata 52W:

$1.065

$2.9789

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Nome

Inovio Pharmaceuticals Inc

Settore

Healthcare (1118)

Industria

Biotechnology (624)

Telefono

(858) 410-3134

Indirizzo

660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA

Dipendente

112

Cinguettio

@inoviopharma

Prossima data di guadagno

2026-03-12

Ultimi documenti SEC

INO's Discussions on Twitter

Compare INO vs VRTX, REGN, ARGX, ALNY, INSM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INO Inovio Pharmaceuticals Inc	1.13	78.07M	65,300	-84.95M	-88.92M	-1.9332
VRTX Vertex Pharmaceuticals Inc	438.71	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.85	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	746.42	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	318.85	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	162.43	35.01B	606.42M	-1.28B	-997.58M	-6.403

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-09	Iniziato	Piper Sandler	Overweight
2024-05-14	Iniziato	Stephens	Overweight
2024-01-25	Aggiornamento	Oppenheimer	Perform → Outperform
2022-11-09	Downgrade	Maxim Group	Buy → Hold
2022-11-01	Downgrade	BofA Securities	Neutral → Underperform
2022-07-19	Ripresa	RBC Capital Mkts	Sector Perform
2022-05-11	Downgrade	Oppenheimer	Outperform → Perform
2022-01-21	Aggiornamento	BofA Securities	Underperform → Neutral
2021-12-29	Ripresa	Jefferies	Hold
2021-09-10	Downgrade	BofA Securities	Neutral → Underperform
2021-06-24	Iniziato	Jefferies	Hold
2021-03-23	Iniziato	BofA Securities	Neutral
2021-02-12	Iniziato	Oppenheimer	Outperform
2020-11-17	Downgrade	ROTH Capital	Neutral → Sell
2020-11-10	Aggiornamento	ROTH Capital	Sell → Neutral
2020-09-28	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2020-09-28	Aggiornamento	Maxim Group	Hold → Buy
2020-07-01	Downgrade	Maxim Group	Buy → Hold
2020-07-01	Downgrade	ROTH Capital	Neutral → Sell
2020-06-29	Downgrade	H.C. Wainwright	Buy → Neutral
2020-06-26	Downgrade	Stifel	Buy → Hold
2020-05-21	Iniziato	The Benchmark Company	Buy
2020-04-30	Downgrade	ROTH Capital	Buy → Neutral
2020-03-13	Downgrade	Piper Sandler	Overweight → Neutral
2020-03-13	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2019-12-19	Iniziato	ROTH Capital	Buy
2018-02-15	Reiterato	Maxim Group	Buy
2017-10-18	Iniziato	RBC Capital Mkts	Outperform
2017-09-06	Iniziato	Citigroup	Buy
2017-06-08	Aggiornamento	Piper Jaffray	Neutral → Overweight
2017-05-24	Reiterato	Maxim Group	Buy
2017-03-16	Aggiornamento	Maxim Group	Hold → Buy
2017-03-16	Downgrade	Piper Jaffray	Overweight → Neutral

Mostra tutto

Inovio Pharmaceuticals Inc Borsa (INO) Ultime notizie

Apr 02, 2026

Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Apr 02, 2026

INO FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO - GlobeNewswire Inc.

Apr 02, 2026

ROSEN, THE FIRST FILING FIRM, Encourages Trip.com Group Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.

Apr 02, 2026

Inovio Pharmaceuticals stock tumbles on dilutive offering By Investing.com - Investing.com Canada

Apr 02, 2026

INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) ... - Bluefield Daily Telegraph

Apr 02, 2026

Inovio Faces New SEC Scrutiny Amidst Stock Sale Plans - stockstotrade.com

Apr 02, 2026

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain OfficersINO - PR Newswire

Apr 02, 2026

Inovio announces pricing of $17.5 million public offering - MarketScreener

Apr 02, 2026

Inovio prices $17.5 million public offering of shares and warrants - MSN

Apr 02, 2026

Inovio prices $17.5M stock offering with warrants - Investing.com

Apr 02, 2026

INOVIO sells 12.5M shares and warrants in $17.5M financing - Stock Titan

Apr 02, 2026

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire

Apr 02, 2026

Inovio Pharmaceuticals Suspends Existing At-the-Market Stock Program - TipRanks

Apr 02, 2026

[424B5] INOVIO PHARMACEUTICALS, INC. Prospectus Supplement (Debt Securities) - Stock Titan

Apr 02, 2026

Inovio Pharmaceuticals suspends at-the-market offering prospectus - investing.com

Apr 02, 2026

According to the latest filings from the US Securities and Exchange Commission (SEC), biotechnology company Inovio Pharmaceuticals has officially suspended and terminated its at-the-market (ATM) equity offering prospectus previously established with inve - Bitget

Apr 02, 2026

Inovio suspends ATM prospectus after $3.2M sold under program - TradingView

Apr 02, 2026

Inovio (NASDAQ: INO) suspends ATM prospectus after selling 1.32M shares - Stock Titan

Apr 02, 2026

Inovio Pharmaceuticals proposes securities offering - MSN

Apr 02, 2026

Biotech INOVIO seeks buyers for stock plus two warrant series - Stock Titan

Apr 02, 2026

INOVIO to Participate in Upcoming Scientific Conference - Sahm

Apr 02, 2026

Apr 01, 2026

Inovio announces proposed public offering of stock and warrants By Investing.com - Investing.com Canada

Apr 01, 2026

INOVIO Announces Proposed Public Offering - PR Newswire

Apr 01, 2026

INOVIO (NASDAQ: INO) CMO converts RSUs; 1,223 shares withheld for taxes - Stock Titan

Apr 01, 2026

INOVIO to show mouse hemophilia treatment data on April 22 - Stock Titan

Apr 01, 2026

Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2026 to Discuss Your RightsINO - PR Newswire

Apr 01, 2026

Mar 31, 2026

INO SEC FilingsInovio Pharmaceu 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 31, 2026

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Mar 31, 2026

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO - ChartMill

Mar 31, 2026

Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. Investors - GlobeNewswire

Mar 31, 2026

INO Stock Price, Quote & Chart | INOVIO PHARMACEUTICALS INC (NASDAQ:INO) - ChartMill

Mar 31, 2026

Inovio Pharmaceuticals Faces Investor Deadline - National Today

Mar 31, 2026

Mar 30, 2026

Volume Summary: Is Inovio Pharmaceuticals Inc a top pick in the sectorWeekly Trend Report & Smart Investment Allocation Tips - baoquankhu1.vn

Mar 30, 2026

INOVIO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, - GlobeNewswire

Mar 30, 2026

Levi & Korsinsky Reminds Inovio Pharmaceuticals, Inc. - GlobeNewswire

Mar 30, 2026